Literature DB >> 11054891

Management of the diabetic Charcot foot.

R G Frykberg1, E Mendeszoon.   

Abstract

The diabetic Charcot foot is a major limb-threatening complication of long-term diabetes mellitus and neuropathy. Although first described over 100 years ago, we are still lacking definitive studies regarding its prevalence in this population, precise etiology, or most effective treatments. Trauma in the presence of peripheral sensory neuropathy and abundant arterial perfusion seem to be the primary causal factors leading to this severe foot deformity. Misdiagnosis or delayed diagnosis of osteoarthropathy allows the destructive phase of this disorder to continue with resultant further destruction of the foot architecture. The authors discuss the natural history of this entity as well as potential treatment options and recommendations. Through a better understanding of the underlying pathogenesis, Charcot arthropathy can be more effectively managed and thereby limit the development of severe deformity, ulceration, infection and limb loss. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11054891     DOI: 10.1002/1520-7560(200009/10)16:1+<::aid-dmrr134>3.0.co;2-n

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  10 in total

Review 1.  [Surgical treatment of the Charcot foot : long-term results and systematic review].

Authors:  N Hartig; S Krenn; H-J Trnka
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

2.  Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy.

Authors:  Mary K Hastings; David R Sinacore; Faye A Fielder; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2005-03

3.  [Reconstructive surgery for Charcot foot. Long-term 5-year outcome].

Authors:  U Illgner; M Podella; M Rümmler; J Wühr; H G Büsch; H H Wetz
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

Review 4.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

5.  Charcot foot? Charcot arthropathy caused by lisfranc fracture-dislocation in a diabetic.

Authors:  Veronica Vasquez; Sean Henderson
Journal:  West J Emerg Med       Date:  2010-05

6.  Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.

Authors:  Niklas Renner; Stephan Hermann Wirth; Georg Osterhoff; Thomas Böni; Martin Berli
Journal:  BMC Musculoskelet Disord       Date:  2016-12-29       Impact factor: 2.362

7.  Treatment of Charcot Neuroarthropathy and osteomyelitis of the same foot: a retrospective cohort study.

Authors:  Martin Berli; Lazaros Vlachopoulos; Sabra Leupi; Thomas Böni; Charlotte Baltin
Journal:  BMC Musculoskelet Disord       Date:  2017-11-16       Impact factor: 2.362

8.  A qualitative study to understand people's experiences of living with Charcot neuroarthropathy.

Authors:  Catherine Gooday; Wendy Hardeman; Frances Game; Jim Woodburn; Fiona Poland
Journal:  Diabet Med       Date:  2022-01-14       Impact factor: 4.213

9.  A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM): a protocol.

Authors:  Catherine Gooday; Frances Game; Jim Woodburn; Fiona Poland; Erika Sims; Ketan Dhatariya; Lee Shepstone; Wendy Hardeman
Journal:  Pilot Feasibility Stud       Date:  2020-06-16

10.  Bone Mineral Density in Diabetes Mellitus Foot Patients for Prediction of Diabetic Neuropathic Osteoarthropathic Fracture.

Authors:  Jae-Ho Cho; Tae-Hong Min; Dong-Il Chun; Sung-Hun Won; Su Yeon Park; Kwonwoo Kim; Young Yi
Journal:  J Bone Metab       Date:  2020-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.